Is Glycolic Acid safe in cosmetics?
Glycolic Acid has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 9 toxicological study endpoint(s) are available in our database.
Also known as: 2-hydroxyacetic acid, 4-03-00-00571, BRN 1209322, Caswell No. 470, EINECS 201-180-5 (+15 more)
INCI: GLYCOLIC ACID
Glycolic Acid (CAS 79-14-1) is a cosmetic active ingredient functioning as Smallest AHA (MW 76 Da) enabling the deepest epidermal penetration of the AHA. Reported NOAEL =150 mg/kg in rat (CIR_vision_codex); EU Regulation 1223/2009 status: restricted, max 10% at pH ≥3.5 (twice-daily leave-on); professional peel concentrations up to 50–75% under controlled conditions only. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 79-14-1 →
Glycolic Acid is classified GHS Danger (H302, H314, H318, H332) in the chemicals database but is restricted in EU cosmetics at max 10% at pH ≥3.5 (twice-daily leave-on); professional peel concentrations up to 50–75% under controlled conditions only.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Glycolic Acid.
Calculate MoS for your specific formulation with the MoS Calculator.
9 study endpoints found for Glycolic Acid. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =150 mg/kg | oral | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =150 mg/kg | oral | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =150 mg/kg | oral | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =150 mg/kg | oral | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =250 mg/kg day | - | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =250 mg/kg day | - | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =250 mg/kg day | - | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =250 mg/kg day | - | rat | developmental toxicity | CIR_vision_codex |
| NOAEL | =150 mg/kg bw/day | oral | Rat | developmental | ToxValDB_ECHA_IUCLID |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Skin absorption and penetration characteristics of Glycolic Acid, relevant to systemic exposure and MoS calculations.
Source: SCCS/1516/13, CIR
6 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| NOAEL | =150 mg/kg-day | Rat | oral | - | ECHA IUCLID |
| NOAEL | =150 mg/kg-day | Rat | oral | - | ECHA IUCLID |
| LC50 | =0.0071 mg/L | Rat | inhalation | - | ChemIDplus |
| LD50 | =1920 mg/kg | Guinea Pig | oral | - | ChemIDplus |
| LD50 | =1950 mg/kg | Rat | oral | - | ChemIDplus |
| LD50 | =1938 mg/kg | Rat | oral | - | HPVIS |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | restricted | 6 | (a) Rinse-off facial products (b) Leave-on facial products |
| AU | restricted | - | exfoliants/peels |
| AE | restricted | 10.0 | Leave-on products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 1.42-30.69 | In vitro; flow-through diffusion cells; [14C]-GA; 24 healthy women donors | Human breast/abdominal skin | Jiang & Qureshi 1998 (J Dermatol Sci); Kraeling 2011 (1998) |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Toner/Exfoliant | 2–10 | 30 | CIR |
| Peel | 20–70 | 70 | CIR |
| Body Lotion | 3–8 | 10 | CIR |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Glycolic Acid.
Public NOAEL study rows linked to Glycolic Acid by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg, mg/kg day
| Absorption % | Method | Vehicle |
|---|---|---|
| 1.42-30.69 | In vitro; flow-through diffusion cells; [14C]-GA; 24 healthy women donors | Aqueous solutions at varying pH and concentration |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Glycolic Acid has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 9 toxicological study endpoint(s) are available in our database.
Glycolic Acid EU regulatory status: restricted. Maximum allowed concentration: 10% at pH ≥3.5 (twice-daily leave-on); professional peel concentrations up to 50–75% under controlled conditions only. This is based on EU Regulation 1223/2009 and its amendments.
Glycolic Acid functions as: Smallest AHA (MW 76 Da) enabling the deepest epidermal penetration of the AHA class. At <25% produces superficial exfoliation; 25–50% causes keratinocyte discontinuity; 50–75% causes epidermolysis. Disrupts desmosomal cohesion via calcium ion chelation, thinning the stratum corneum and promoting cell turnover. Efficacy governed by free (undissociated) acid concentration per Henderson-Hasselbalch: at pH 3.5 (~68% free acid) vs pH 4.5 (~18% free acid). Also used as pH adjuster.. It is classified as a Active Ingredient in our database. CAS number: 79-14-1.
The NOAEL (No Observed Adverse Effect Level) for Glycolic Acid is =150 mg/kg based on a developmental toxicity study via oral route in rat. A total of 9 study endpoints are available. Source: CIR_vision_codex.
Glycolic Acid also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Glycolic Acid is classified GHS Danger (H302, H314, H318, H332) in the chemicals database but is restricted in EU cosmetics at max 10% at pH ≥3.5 (twice-daily leave-on); professional peel concentrations up to 50–75% under controlled conditions only.
Check Glycolic Acid compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Glycolic Acid in your formulation.